ICCM (Icecure Medical) Moat Score: 2/10 (As of Jun. 30, 2026)


ICCM Icecure Medical Ltd ICCM
46 GF Score
Price $5.37
GF Value $21.37
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Icecure Medical Moat Score?

Icecure Medical ICCM -11.07% 46 Moat Score is 2 as of Jun. 30, 2026. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.37 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Icecure Medical ranks better than 68.2% on this metric.

Icecure Medical has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Icecure Medical has No Moat: Icecure Medical Ltd has limited market leadership and lacks significant customer switching costs or strong brand loyalty. The company operates in a competitive medical device industry with minimal regulatory barriers and no significant cost advantages or intellectual property that would provide a durable competitive edge.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Icecure Medical might have No Moat - Very weak/transient advantages.

Icecure Medical  (NAS:ICCM) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Icecure Medical Moat Score Related Terms

ICCM vs LFWD, IRIX, GTHP: Moat Score Comparison

For the Medical Devices subindustry, Icecure Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Icecure Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where Icecure Medical's Moat Score falls into.


ICCM
46GF Score
Icecure Medical Ltd ICCM
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Icecure Medical (ICCM) has a Moat Score of 2 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Icecure Medical ranks #269 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 31.8%.
Is Icecure Medical's Moat Score too high?
Icecure Medical's current Moat Score is 2. Based on the distribution chart, Icecure Medical ranks #269 out of 846 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's Moat Score compare to LFWD and IRIX?
According to the Medical Devices & Instruments industry distribution chart, Icecure Medical ranks #269 out of 846 companies for Moat Score. This puts Icecure Medical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Icecure Medical's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.37, compared to a current price of $5.37 — trading 74.9% below its estimated fair value. The current Moat Score is 2. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Icecure Medical (ICCM), the current Moat Score is 2 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icecure Medical (ICCM) Overvalued in 2026?

Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued. The current stock price of $5.37 is trading 74.9% below its estimated GF Value™ of $21.37. GuruFocus considers Icecure Medical to be Possible Value Trap.

Key valuation signals for ICCM:

  • Moat Score: 2
  • GF Value™: $21.37 vs. price of $5.37 (74.9% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icecure Medical Business Description

Address 7 Haeshel Street, PO Box 3163, Caesarea, ISR, 3079504
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score

Get the complete analysis for ICCM

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.37
Price
$21.37
GF Value